The Food Safety and Standards Authority of India (FSSAI) has opened formal proceedings against Nestle India and Zydus Wellness, citing unsubstantiated health claims on their packaging and digital advertising. The regulator also targeted an unidentified Instagram influencer for promoting infant formula, marking a significant escalation in digital enforcement.
For Nestle, the scrutiny centers on two products: NAN Excella Pro Stage 1 and Lactogen Pro 1 Powder. The FSSAI specifically challenged the claim that "5 HMOs (Human Milk Oligosaccharides) helps support normal immune system," noting that such physiological benefits are not permitted under current regulations. The agency demanded scientific proof that whey protein is "easy to digest" and similar evidence for Lactogen.
Zydus Wellness faced a separate show-cause notice over Complan. The regulator flagged the marketing claim that the drink promotes "2 times faster growth" as misleading. The company has been directed to submit explanations, documents, and the scientific basis supporting this assertion.
Dr Arun Gupta, founder of the Breastfeeding Promotion Network of India (BPNI), welcomed the action. He emphasized that the 1992 Infant Milk Substitutes, Feeding Bottles and Infant Foods Act must remain effective in the digital age. Gupta urged FSSAI to investigate thoroughly and initiate prosecution to create a deterrent against future violations.